EVALUATING THE THERAPEUTIC POTENTIAL OF Cuscuta reflexa AND Saussurea lappa IN THE MANAGEMENT OF MELASMA: A SINGLE BLIND RANDOMIZED CLINICAL TRIAL
DOI:
https://doi.org/10.48165/abr.2025.27.01.58Keywords:
Cuscuta reflexa, decoction, hyperpigmentation, melasma, Saussurea lappaAbstract
To scientifically validate the drugs traditionally used by Arab and Greek physicians, a single blind, randomized, standard-controlled clinical trial was conducted on 36 melasma patients aged 15-50 years, with treatment duration of 60 days. The study aimed to evaluate the efficacy of a test drug formulation comprising of a decoction of Cuscuta reflexa and a paste of Sausserea lappa (mixed with honey), compared to the recommended allopathic treatment (standard control). The test group received a decoction of C. reflexa (5 g orally, once a day) along with topical application of S. lappa paste on the affected area for 15 min once a day. The control group was orally administered with tranxemic acid tablets (250 mg, twice daily) and topical azelaic acid (10%) on the affected area. The test group exhibited significant improvement in subjective parameters with significant decrease in the severity of hyper pigmentation. Both the groups showed significant improvement in objective parameters including melasma area and severity index (MASI) scores, by the 60th day of treatment (p < 0.001). The test drugs demonstrated noticeable therapeutic effects on both subjective and objective parameters, without any adverse effect. No significant difference was observed between test and standard control treatment.Downloads
References
Abdalla MA. Melasma clinical features, diagnosis, epidemiology and etiology: An update review. Siriraj Med J. 2021;73(12):841-850.
Al-Rais AAH, Kinturi GH. Al-Qanun fil Tibb (The Canon of Medicine). Vol. 1. New Delhi: Idara Kitab al-Shifa; 2010.
Baghdadi IH. Kitab ul Mukhtarat fit Tibb. New Delhi: Central Council for Research in Unani Medicine (CCRUM); 2005.
Bala HR, Lee S, Wong C, Pandya AG, Rodrigues M. Oral tranexamic acid for the treatment of melasma: A review. Dermatol Surg. 2018;44:814-825.
Chen Y, Vellaichamy G, Schneider SL, Kong W, Liu Z. Exposure factors in the occurrence and development of melasma. Exp Ther Med. 2024;31:131. Available from: https://www.spandidos-publications.com/10.3892/etm.2024.12419
Choodej S, Pudhom K, Yamauchi K, Mitsunaga T. Inhibition of melanin production by sesquiterpene lactones from Saussurea lappa and their analogues. Med Chem Res. 2019;28:857-862.
Doolan BJ, Gupta M. Melasma. Aust J Gen Pract. 2021;50:880-885.
Espósito ACC, Cassiano DP, da Silva CN, Lima PB, Dias JA, Hassun K, et al. Update on melasma – Part I: Pathogenesis. Dermatol Ther. 2022;12:1967-1988.
Gangarde P, Kuchekar B, Kuchekar A, Gawade A, Pujari R. Cuscuta reflexa Roxb.: A special emphasis on its anticancer, antimicrobial, anti-inflammatory, immunomodulatory potential. Res J Pharm Technol. 2024;17(10):5055-5061.
Gopichandani K, Arora P, Garga U, Bhardwaj M, Sharma N, Gautam RK. Hormonal profile of melasma in Indian females. Pigment Int. 2015;2:85-90.
How KN, Lim PY, Wan Ahmad Kammal WSL, Shamsudin N. Efficacy and safety of Jessner’s solution peel in comparison with salicylic acid 30% peel in the management of acne vulgaris and post-acne hyperpigmentation in skin of color: A randomized double-blinded split-face controlled trial. Int J Dermatol. 2020;59:804-812.
Jo JY, Chae SJ, Ryu HJ. Update on melasma treatments. Ann Dermatol. 2024;36:125. doi:10.5021/ad.23.133
Kalam MA, Ahmad G, Shahzad A, Maqbul SAA, Akhtar MS. Therapeutic potential of rhizomatous plants used in Unani medicare system. In: Swamy MK, Akbar MS, editors. Natural Bio-active Compounds. Vol 2. Singapore: Springer; 2019. p.409-464.
Khalid M, Husain N, Rahmatullah M, Alam A, Beg MU. A comprehensive review on the medicinal benefits of honey with emphasis on Unani medicine. Curr Tradit Med. 2023;9(5):13-22.
Khan A. Al-Haziq. 1st ed. Karachi: Madina Publishing Co.; 1983.
Kimbrough-Green CK, Griffiths CE, Finkel LJ, Hamilton TA, Bulengo-Ransby SM, Ellis CN, et al. Topical tretinoin for melasma in black patients: A vehicle-controlled clinical trial. Arch Dermatol. 1994;130:727-733.
Liao JC, Chang WT, Lee MS, Chiu YJ, Chao WK, Lin YC, et al. Antinociceptive and anti-inflammatory activities of Cuscuta chinensis seeds in mice. Am J Chin Med. 2014;42:223-242.
Liu W, Chen Q, Xia Y. New mechanistic insights of melasma. Clin Cosmet Investig Dermatol. 2023;16:429-442.
Manasa SJ. A comparative study on the efficacy of topical 5% tranexamic acid solution vs 3% hydroquinone cream in melasma [dissertation]. Bengaluru: Rajiv Gandhi University of Health Sciences; 2018.
Nijhawan LP, Janodia MD, Muddukrishna BS, Bhat KM, Bairy KL, Udupa N, et al. Informed consent: Issues and challenges. J Adv Pharm Technol Res. 2013;4:134-140.
Ogbechie-Godec OA, Elbuluk N. Melasma: An up-to-date comprehensive review. Dermatol Ther. 2017;7:305-318.
Pandya A, Berneburg M, Ortonne JP, Picardo M. Guidelines for clinical trials in melasma. Br J Dermatol. 2007;156(Suppl 1):21-28.
Phansuk K, Vachiramon V, Jurairattanaporn N, Chanprapaph K, Rattananukrom T. Dermal pathology in melasma: An update review. Clin Cosmet Investig Dermatol. 2022;15:11-19.
Popaniya HS, Vaja PN, Chintankumar J, Tank CJ. Tyrosinase inhibition: A potent mechanism of action of plants used in treatment of melasma. Asian J Pharm Res. 2024;14:289-294.
Roohaninasab M, Mojtabaee M, Livani F, Heidari N, Alizadeh N, Khosravi S, et al. Beneficial aesthetic lightening effects of Cuscuta extract on skin darkness in healthy individuals: A clinical trial study. J Fam Med Prim Care. 2022;11:6890-6895.
Shah S, Narang T. Quality of life scales in pigmentary disorders. Pigment Int. 2023;10:142-147.
Sidharth S. Etiopathogenesis of melasma. In: Sarkar S, editor. Melasma: A Monograph. New Delhi: Jaypee Publishers; 2015. p.6-14.
Singh J. Randomization and online databases for clinical trials. J Pharmacol Pharmacother. 2014;5:173-174.
Sonthalia S, Sarkar R. Etiopathogenesis of melasma. Pigment Int. 2015;2:21-27.
Trelles MA, Velez M, Gold MH. Treatment of melasma with topical creams alone, CO₂ fractional resurfacing alone, or combination therapy: A comparative study. J Drugs Dermatol. 2010;9:315-322.
Varghese N. A clinico-demographic and dermoscopic evaluation of melasma and exogenous ochronosis in Indian patients [dissertation]. Bengaluru: Rajiv Gandhi University of Health Sciences; 2019.
Wang L, Yang K, Jing R, Zhao W, Guo K, Hu Z, et al. Protective effect of Saussurea involucrata polysaccharide against ultraviolet-induced skin dryness. Front Pharmacol. 2023;14:1089537. doi:10.3389/fphar.2023.1089537
Wang TJ, An J, Chen XH, Deng QD, Yang L. Assessment of Cuscuta chinensis seed’s effect on melanogenesis: Comparison of water and ethanol fractions in vitro and in vivo. J Ethnopharmacol. 2014;154:240-248.
World Medical Association. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194.
